首页> 外文期刊>Journal of applied statistics >Using repeated-prevalence data in multi-state modeling of renal replacement therapy
【24h】

Using repeated-prevalence data in multi-state modeling of renal replacement therapy

机译:在肾脏替代疗法的多状态建模中使用重复患病率数据

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Multi-state models help predict future numbers of patients requiring specific treatments but these models require exhaustive incidence data. Deriving reliable predictions from repeated-prevalence data would be helpful. A new method to model the number of patients that switch between therapeutic modalities using repeated-prevalence data is presented and illustrated. The parameters and goodness of fit obtained with the new method and repeated-prevalence data were compared to those obtained with the classical method and incidence data. The multi-state model parameters' confidence intervals obtained with annually collected repeated-prevalence data were wider than those obtained with incidence data and six out of nine pairs of confidence intervals did not overlap. However, most parameters were of the same order of magnitude and the predicted patient distributions among various renal replacement therapies were similar regardless of the type of data used. In the absence of incidence data, a multi-state model can still be successfully built with annually collected repeated-prevalence data to predict the numbers of patients requiring specific treatments. This modeling technique can be extended to other chronic diseases.
机译:多状态模型有助于预测未来需要特定治疗的患者人数,但是这些模型需要详尽的发病率数据。从重复流行率数据得出可靠的预测将很有帮助。提出并说明了一种使用重复患病率数据对在治疗方式之间切换的患者数量进行建模的新方法。比较了用新方法和重复患病率数据获得的参数和拟合优度与用经典方法和发病率数据获得的参数和拟合优度。每年收集的重复流行数据所获得的多状态模型参数的置信区间比发病率数据所获得的多,并且九对置信区间中的六对没有重叠。但是,大多数参数都处于相同的数量级,并且无论使用何种数据类型,各种肾脏替代疗法之间的预测患者分布均相似。在没有发病率数据的情况下,仍可以使用每年收集的重复患病率数据成功建立多状态模型,以预测需要特定治疗的患者人数。这种建模技术可以扩展到其他慢性疾病。

著录项

  • 来源
    《Journal of applied statistics》 |2015年第6期|1278-1290|共13页
  • 作者单位

    Hosp Civils Lyon, Serv Biostat, F-67003 Lyon, France|Univ Lyon 1, Dept Biol Humaine, F-69100 Villeurbanne, France|CNRS, UMR5558, Lab Biomet & Biol Evolut, Equipe Biostat Sante, F-69100 Villeurbanne, France;

    Hosp Civils Lyon, Serv Biostat, F-67003 Lyon, France|Univ Lyon 1, Dept Biol Humaine, F-69100 Villeurbanne, France|CNRS, UMR5558, Lab Biomet & Biol Evolut, Equipe Biostat Sante, F-69100 Villeurbanne, France;

    Hosp Civils Lyon, Serv Biostat, F-67003 Lyon, France|Univ Lyon 1, Dept Biol Humaine, F-69100 Villeurbanne, France|CNRS, UMR5558, Lab Biomet & Biol Evolut, Equipe Biostat Sante, F-69100 Villeurbanne, France;

    Univ Lyon 1, Dept Biol Humaine, F-69100 Villeurbanne, France|Hosp Civils Lyon, Serv Nephrol Dialyse & Transplantat Renale, Ctr Hosp Lyon Sud, F-69310 Pierre Benite, France|Ctr Hosp St Joseph St Luc, Serv Nephrol & Dialyse, F-69007 Lyon, France;

    Agence Biomed, Registre REIN, F-93210 La Plaine St Denis, France;

    Hosp Civils Lyon, Serv Biostat, F-67003 Lyon, France|Univ Lyon 1, Dept Biol Humaine, F-69100 Villeurbanne, France|CNRS, UMR5558, Lab Biomet & Biol Evolut, Equipe Biostat Sante, F-69100 Villeurbanne, France;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    62F30 inference under constraints; renal dialysis; statistical models; organ transplantation; chronic disease; prevalence; chronic kidney failure;

    机译:约束条件下的62F30推论;肾脏透析;统计模型;器官移植;慢性疾病;患病率;慢性肾功能衰竭;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号